Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beer

Showing results (251-260 of 321) with videos related to

Pageof 33
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinomaDaniel L Albertus, Christopher W Seder, Guoan Chen, et al.
Endoscopy|March 17, 2022
Detection of Barrett's neoplasia with a near-infrared fluorescent heterodimeric peptideJing Chen, Yang Jiang, Tse-Shao Chang, et al.
Gastroenterology|November 13, 2019
Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal CellsDipankar Ray, Paramita Ray, Daysha Ferrer-Torres, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
Oncotarget|June 13, 2015
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinomaJules Lin, Amy L Myers, Zhuwen Wang, et al.
Molecular Pharmaceutics|July 17, 2019
Correction to "Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application"Xiaowen Ma, Xiaoyu Kang, Lei He, et al.
Molecular Pharmaceutics|April 13, 2019
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical ApplicationXiaowen Ma, Xiaoyu Kang, Lei He, et al.
Cancer Biology & Therapy|March 25, 2015
Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine modelsShannon D McClintock, Roscoe L Warner, Saqib Ali, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Pageof 33

Showing results (251-260 of 321) with videos related to

Sort By:
Pageof 33
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinomaDaniel L Albertus, Christopher W Seder, Guoan Chen, et al.
Endoscopy|March 17, 2022
Detection of Barrett's neoplasia with a near-infrared fluorescent heterodimeric peptideJing Chen, Yang Jiang, Tse-Shao Chang, et al.
Gastroenterology|November 13, 2019
Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal CellsDipankar Ray, Paramita Ray, Daysha Ferrer-Torres, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
Oncotarget|June 13, 2015
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinomaJules Lin, Amy L Myers, Zhuwen Wang, et al.
Molecular Pharmaceutics|July 17, 2019
Correction to "Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application"Xiaowen Ma, Xiaoyu Kang, Lei He, et al.
Molecular Pharmaceutics|April 13, 2019
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical ApplicationXiaowen Ma, Xiaoyu Kang, Lei He, et al.
Cancer Biology & Therapy|March 25, 2015
Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine modelsShannon D McClintock, Roscoe L Warner, Saqib Ali, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Pageof 33